Bleeding risk on warfarin among elderly patients with atrial fibrillation.
作者信息
Cowan Andrew, Hylek Elaine M
出版信息
J Am Coll Cardiol. 2010 Mar 2;55(9):932; author reply 932-3. doi: 10.1016/j.jacc.2009.11.037.
PMID:20185052
Abstract
摘要
相似文献
1
Bleeding risk on warfarin among elderly patients with atrial fibrillation.老年房颤患者服用华法林后的出血风险
J Am Coll Cardiol. 2010 Mar 2;55(9):932; author reply 932-3. doi: 10.1016/j.jacc.2009.11.037.
2
Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.用希美加群或华法林治疗的非瓣膜性心房颤动患者出血情况的比较：出血发生率、病死率、时间进程、出血部位及出血危险因素的评估
Arch Intern Med. 2006 Apr 24;166(8):853-9. doi: 10.1001/archinte.166.8.853.
3
Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.老年房颤患者（包括有跌倒和/或早期痴呆症的患者）预防卒中的抗凝治疗：一项单中心、回顾性、观察性研究。
Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.
4
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.正方观点：“华法林应该是老年房颤患者血栓预防的首选药物”。为什么华法林确实应该成为老年房颤患者预防中风的首选药物。
Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.
5
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.反对观点：“华法林应是老年房颤患者血栓预防的首选药物”。关于老年房颤患者使用口服抗凝治疗的注意事项。
Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.
6
Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.影响心房颤动患者抗凝治疗期间出血风险的因素：来自节律管理心房颤动随访调查（AFFIRM）研究的观察结果
Am Heart J. 2005 Apr;149(4):650-6. doi: 10.1016/j.ahj.2004.11.015.
7
Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.心房颤动患者抗栓治疗期间的出血。心房颤动预防卒中研究组。
Arch Intern Med. 1996 Feb 26;156(4):409-16.
8
Dabigatran for stroke prevention in all patients with atrial fibrillation?达比加群用于所有房颤患者的卒中预防？
Pharmacotherapy. 2011 Aug;31(8):725-8. doi: 10.1592/phco.31.8.725.
9
Stroke in heart failure: atrial fibrillation revisited?心力衰竭中的中风：重新审视心房颤动？
J Stroke Cerebrovasc Dis. 2010 Jan;19(1):1-2. doi: 10.1016/j.jstrokecerebrovasdis.2009.09.002.
10
[Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation].华法林与阿司匹林预防老年房颤患者卒中的对比研究
Nan Fang Yi Ke Da Xue Xue Bao. 2006 Jun;26(6):851-2, 855.
Zotero 插件